Meeder Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7
Closed -$3.6K 965
2025
Q3
$3.6K Buy
+7
New +$3.06K ﹤0.01% 721
2022
Q4
Sell
-551
Closed -$87K 1491
2022
Q3
$87K Sell
551
-63
-10% -$10.1K 0.01% 720
2022
Q2
$92K Sell
614
-126
-17% -$18.2K 0.01% 746
2022
Q1
$121K Buy
+740
New +$122K 0.01% 762
2021
Q4
Sell
-687
Closed -$130K 1847
2021
Q3
$130K Sell
687
-46
-6% -$8.39K 0.01% 832
2021
Q2
$129K Buy
733
+6
+0.8% +$1.04K 0.01% 842
2021
Q1
$119K Buy
727
+715
+5,958% +$109K 0.01% 871
2020
Q4
$2K Buy
12
+5
+71% +$630 ﹤0.01% 1505
2020
Q3
$1K Buy
7
+1
+17% +$116 ﹤0.01% 2003
2020
Q2
$1K Buy
+6
New +$511 ﹤0.01% 1932

Other funds holding MEDP

Meeder Asset Management's MEDP Position: Q4 2025 in Review

Meeder Asset Management sold out of Medpace (MEDP) in Q4 2025, closing a stake of 7 shares — an estimated $3.6K sold.

Meeder Asset Management first reported a position in MEDP in Q2 2020 and held it in 10 quarters. The position peaked at $130K in Q3 2021. 786 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Meeder Asset Management reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Meeder Asset Management sold 7 Medpace shares in Q4 2025, an estimated $3.6K.
  • Meeder Asset Management first reported a position in Medpace in Q2 2020 and held it in 10 quarters.
  • Meeder Asset Management's Medpace position peaked at $130K in Q3 2021.
  • 786 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Meeder Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.